Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel
Amita Gupta(Johns Hopkins University), Amina White(National Institutes of Health Clinical Center), Radojka M. Savić(University of California, San Francisco), Sonia Hernández–Dı́az(Harvard University), Kelly E. Dooley(Johns Hopkins University), Jyoti S. Mathad(Cornell University), Liza Dawson(National Institute of Allergy and Infectious Diseases), Patrick Jean‐Philippe(Jackson Foundation), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Devasena Gnanashanmugam(Johns Hopkins University), Hans Spiegel(Aaron Diamond AIDS Research Center), Jeanna Piper(National Institute of Allergy and Infectious Diseases), Radu Botgros, D. Heather Watts(National Institutes of Health), Vikki Brown(INC Research (United States)), Soumya Swaminathan(M S Swaminathan Research Foundation), Leyla Şahin, Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Grace Montepiedra(Cancer Research And Biostatistics), Betsy Smith(National Institute of Allergy and Infectious Diseases), Peter Kim(National Institute of Allergy and Infectious Diseases), Jessica D. Albano, Renee Browning(Johns Hopkins University), Susan M. Abdel‐Rahman(Children's Mercy Hospital), Mark Mirochnick(Boston University), Anne Drapkin Lyerly(University of North Carolina at Chapel Hill)
Cited by 65
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k